Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptorγ-hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertension
about
Hepatocyte Growth Factor Prevented High-Fat Diet-Induced Obesity and Improved Insulin Resistance in Mice.Recent Advances of Curcumin in the Prevention and Treatment of Renal Fibrosis.Hepatocyte growth factor, a biomarker of macroangiopathy in diabetes mellitus.Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient miceRole of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension.Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to benchParacrine Effects of Adipose-Derived Stem Cells on Matrix Stiffness-Induced Cardiac Myofibroblast Differentiation via Angiotensin II Type 1 Receptor and Smad7Madecassoside ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting the generation of hepatocyte growth factor via PPAR-γ in colon.Modeling of the pharmacokinetic/pharmacodynamic interaction between irbesartan and hydrochlorothiazide in normotensive subjects.Novel Anti-fibrotic Therapies.Renoprotective effect of renal liver-type fatty acid binding protein and angiotensin II type 1a receptor loss in renal injury caused by RAS activation.The potential signaling pathway between peroxisome proliferator-activated receptor gamma and retinoic acid receptor alpha in renal interstitial fibrosis disease.Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal failure.
P2860
Q33669422-6357721A-B8FD-4EA3-9E8D-452AFA2C7F36Q33701346-D7BC86F6-0D5E-41E6-911C-9CDC494383E4Q34068447-3653AE8F-5F9C-4656-A53B-2FE0A6DC4D51Q34997831-956E52AF-C957-4997-B96F-F706E2BED585Q37071386-95C480E5-9B05-4F0C-B91E-A83301F88FC0Q37171547-F5A0FDAA-8AD2-40C3-8689-6FEFC015ECFDQ37310715-6DC6DE05-F4A3-44E8-9FF5-A722B4917DA4Q37686310-3A597AD5-606B-4C8A-9DD1-604BC7C6BA4CQ38418522-1088454D-506A-4B32-AA96-3AE6C0913BAAQ39377055-B3FD47FA-8254-453E-834C-305F44E18BABQ46945650-C034F1DF-46E4-4211-90F0-37345DF57CD1Q53007399-5A12632B-466E-4D62-8713-319835563DF2Q54402246-1E430059-FBAF-4AE2-8C75-C4C3574F6BFF
P2860
Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptorγ-hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertension
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Cardiac and renal protective e ...... of salt-sensitive hypertension
@en
type
label
Cardiac and renal protective e ...... of salt-sensitive hypertension
@en
prefLabel
Cardiac and renal protective e ...... of salt-sensitive hypertension
@en
P2093
P2860
P356
P1476
Cardiac and renal protective e ...... of salt-sensitive hypertension
@en
P2093
Hiroshi Kusunoki
Ryuichi Morishita
Yoshiaki Taniyama
P2860
P304
P356
10.1161/JAHA.113.000103
P577
2013-04-22T00:00:00Z